We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.5B
AUM Growth
+$70.4M
Cap. Flow
+$56.7M
Cap. Flow %
3.77%
Top 10 Hldgs %
18.77%
Holding
2,395
New
342
Increased
861
Reduced
697
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 17.26%
2 Healthcare 13.68%
3 Financials 11.69%
4 Consumer Discretionary 10.93%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
1976
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
+19
New +$1.79K
SIX
1977
DELISTED
Six Flags Entertainment Corp.
SIX
$2K ﹤0.01%
31
+12
+63% +$651
ICD
1978
DELISTED
Independence Contract Drilling, Inc.
ICD
$2K ﹤0.01%
96
CBAY
1979
DELISTED
Cymabay Therapeutics
CBAY
$2K ﹤0.01%
404
-1,586
-80% -$9.6K
PRTK
1980
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2K ﹤0.01%
+555
New +$2.22K
IDEX
1981
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$2K ﹤0.01%
+9
New +$2.04K
SPPI
1982
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2K ﹤0.01%
+204
New +$1.65K
MAXR
1983
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$2K ﹤0.01%
271
-18
-6% -$143
CHRA
1984
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$2K ﹤0.01%
80
+53
+196% +$2.09K
CLVS
1985
DELISTED
Clovis Oncology, Inc.
CLVS
$2K ﹤0.01%
585
+331
+130% +$2.68K
ELOX
1986
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$2K ﹤0.01%
14
GBT
1987
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2K ﹤0.01%
40
ATHX
1988
DELISTED
Athersys, Inc. Common Stock
ATHX
$2K ﹤0.01%
52
PLAN
1989
DELISTED
Anaplan, Inc.
PLAN
$2K ﹤0.01%
+47
New +$2.55K
CMD
1990
DELISTED
Cantel Medical Corporation
CMD
$2K ﹤0.01%
22
-49
-69% -$4.15K
GLIBA
1991
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$2K ﹤0.01%
29
CHAP
1992
DELISTED
Chaparral Energy, Inc.
CHAP
$2K ﹤0.01%
+1,349
New +$3.73K
WBC
1993
DELISTED
WABCO HOLDINGS INC.
WBC
$2K ﹤0.01%
18
-961
-98% -$128K
S
1994
DELISTED
Sprint Corporation
S
$2K ﹤0.01%
308
-223
-42% -$1.53K
INXN
1995
DELISTED
Interxion Holding N.V.
INXN
$2K ﹤0.01%
23
DERM
1996
DELISTED
Dermira, Inc.
DERM
$2K ﹤0.01%
285
-297
-51% -$2.48K
WCG
1997
DELISTED
Wellcare Health Plans, Inc.
WCG
$2K ﹤0.01%
6
-110
-95% -$30.4K
ROAN
1998
DELISTED
Roan Resources, Inc.
ROAN
$2K ﹤0.01%
+1,907
New +$2.48K
WPG
1999
DELISTED
Washington Prime Group Inc.
WPG
$2K ﹤0.01%
58
+6
+12% +$198
FNM
2000
DELISTED
FANNIE MAE
FNM
$2K ﹤0.01%
+409
New +$2K

Similar funds

Meeder Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Meeder Asset Management held 2,395 positions worth $1.5B, up 4.9% from $1.43B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Meeder Asset Management deployed $56.7M of net new capital in Q3 2019, opening 342 new positions and adding to 861 existing holdings. Its largest new stake was Xtrackers USD High Yield Corporate Bond ETF: 159,135 shares worth $6.38M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $8.11M trimmed.

  • Meeder Asset Management's largest Q3 2019 buy was Xtrackers USD High Yield Corporate Bond ETF: 159,135 shares worth $6.38M.
  • Meeder Asset Management added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $23M increase.
  • Meeder Asset Management's biggest Q3 2019 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $8.11M.
  • Meeder Asset Management fully exited Black Hills Corp in Q3 2019, selling an estimated $1.74M.
  • Meeder Asset Management's ten largest holdings make up 19% of its $1.5B portfolio in Q3 2019.
  • Meeder Asset Management opened 342 new positions and closed 208 in Q3 2019.
  • Meeder Asset Management's portfolio value rose 4.9% quarter-over-quarter to $1.5B.

Based on Meeder Asset Management's 13F filing for Q3 2019, filed 17 Oct 2019.